Molecular Classification
Enzyme, Oxidoreductase (for prolyl and lysyl hydroxylases), Glycosyltransferase (for glycosylation enzymes)
Other Names
Collagen biosynthesis enzyme, Collagen-modifying enzyme, Prolyl hydroxylase, Lysyl hydroxylase, Procollagen-lysine 2-oxoglutarate 5-dioxygenase, Matrix metalloproteinase (for degradation phase)
Disease Roles
Connective tissue disordersCancer metastasisFibrosis

Collagen synthesis pathway enzyme Overview

Collagen synthesis pathway enzymes refer collectively to the group of intracellular enzymes responsible for the post-translational modifications required for proper collagen biosynthesis. The most critical among these are **prolyl 4-hydroxylases**, **prolyl 3-hydroxylases**, and **lysyl hydroxylases**. These enzymes catalyze the hydroxylation of specific proline and lysine residues in procollagen chains within the endoplasmic reticulum. This modification is essential for stabilizing the triple-helical structure of collagen molecules through hydrogen bonding and facilitating subsequent glycosylation events[1][2][3][4][5]. Hydroxylysines also serve as sites for further glycosylation by galactosyltransferases. After secretion into the extracellular space, additional processing occurs via proteolytic cleavage by procollagen peptidases to form mature tropocollagen[9]. Cross-linking between tropocollagens is mediated by lysyl oxidase. Defects or dysregulation in these enzymes can result in connective tissue disorders such as Ehlers-Danlos syndrome or contribute to pathological fibrosis and tumor metastasis due to abnormal extracellular matrix remodeling[2]. **Note:** "Collagen synthesis pathway enzymes" is not a single molecular target but rather a functional group comprising several distinct but related enzymatic proteins involved in collagen biosynthesis. For structured data purposes, it would be more accurate to specify individual targets such as "Prolyl 4-hydroxylase" or "Lysyl hydroxylase," each with their own gene/protein identifiers (e.g., P4HA1/PLOD1)[1][2][3].

Mechanism of Action

Inhibition of enzymatic activity to reduce collagen cross-linking or stability[2]

Biological Functions

Post-translational modification
Extracellular matrix organization
Protein folding and maturation

Disease Associations

Connective tissue disorders
Cancer metastasis
Fibrosis

Safety Considerations

  • Impaired wound healing with inhibition

Interacting Drugs

None specific; some inhibitors of prolyl hydroxylases are under investigation for fibrotic diseases and cancer[2]

Associated Biomarkers

Biomarker
Hydroxyproline levels (as a marker of collagen turnover)